Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Revance Therapeutics
(NQ:
RVNC
)
2.800
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EDT, Jun 18, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
1,429,097
Open
2.780
Bid (Size)
2.750 (3)
Ask (Size)
2.850 (7)
Prev. Close
2.800
Today's Range
2.735 - 2.900
52wk Range
2.570 - 29.43
Shares Outstanding
71,829,718
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Revance Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
June 14, 2024
From
Revance Therapeutics, Inc.
Via
Business Wire
Revance to Participate in Upcoming Investor Conferences
May 28, 2024
From
Revance Therapeutics, Inc.
Via
Business Wire
Performance
YTD
-69.92%
-69.92%
1 Month
-11.39%
-11.39%
3 Month
-43.20%
-43.20%
6 Month
-66.02%
-66.02%
1 Year
-90.28%
-90.28%
More News
Read More
The 100%+ Club: Piper Sandler’s 3 Top Picks for Triple-Digit Gains
May 22, 2024
Via
InvestorPlace
3 Underappreciated Stocks That Could 10x in 10 Years
May 12, 2024
Via
InvestorPlace
12 Health Care Stocks Moving In Friday's Intraday Session
May 10, 2024
Via
Benzinga
Earnings Outlook For Revance Therapeutics
February 27, 2024
Via
Benzinga
Why Diodes Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Friday's Mid-Day Session
May 10, 2024
Via
Benzinga
These Analysts Lower Their Forecasts On Revance Therapeutics After Q1 Results
May 10, 2024
Via
Benzinga
RVNC Stock Earnings: Revance Therapeutics Beats EPS, Misses Revenue for Q1 2024
May 09, 2024
Via
InvestorPlace
Revance Reports First Quarter 2024 Financial Results, Provides Corporate Update
May 09, 2024
From
Revance Therapeutics, Inc.
Via
Business Wire
Revance Expands into the U.S. Therapeutics Market with the Launch of DAXXIFY® for the Treatment of Cervical Dystonia
May 09, 2024
From
Revance Therapeutics, Inc.
Via
Business Wire
Revance to Release First Quarter 2024 Financial Results on Thursday, May 9, 2024
May 02, 2024
From
Revance Therapeutics, Inc.
Via
Business Wire
Revance to Present New DAXXIFY® Data at the American Academy of Neurology 2024 Annual Meeting
April 12, 2024
From
Revance Therapeutics, Inc.
Via
Business Wire
BlackBerry, Nurix Therapeutics, Tesla And Other Big Stocks Moving Higher On Tuesday
April 09, 2024
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Revance Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
March 27, 2024
From
Revance Therapeutics, Inc.
Via
Business Wire
GDS Holdings, Coinbase And Other Big Stocks Moving Higher In Monday's Pre-Market Session
March 11, 2024
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Why Bitdeer Technologies Shares Are Trading Higher By 10%? Here Are Other Stocks Moving In Monday's Mid-Day Session
March 04, 2024
Via
Benzinga
Tesla, Spirit Airlines, New York Community Bancorp And Other Big Stocks Moving Lower On Monday
March 04, 2024
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Revance Announces Pricing of $100.0 Million Public Offering of Common Stock
March 04, 2024
From
Revance Therapeutics, Inc.
Via
Business Wire
Revance Announces Proposed Public Offering of Common Stock
March 04, 2024
From
Revance Therapeutics, Inc.
Via
Business Wire
Why Butterfly Network Shares Are Trading Lower By 22%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
February 29, 2024
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
February 29, 2024
Via
Benzinga
Hormel Foods Reports Upbeat Earnings, Joins Pure Storage, Okta, Papa John's International And Other Big Stocks Moving Higher On Thursday
February 29, 2024
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Revance Reports Fourth Quarter and Full Year 2023 Financial Results, Provides Corporate Update
February 28, 2024
From
Revance Therapeutics, Inc.
Via
Business Wire
Earnings Scheduled For February 28, 2024
February 28, 2024
Via
Benzinga
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.